HTB

Cancer and HIV

Report from the IAS HIV Cure & Cancer Forum, 22–23 July 2017, Paris

Poppers and cancer risk in HIV negative and HIV positive gay men

Anal cancer and HPV screening in HIV positive people

UK guidelines for HIV-related cancers: 2014 edition published online

Promising outcomes from laser ablative treatment of AIN2/3 to prevent anal cancer

T-cell senescence linked to KS in peoplewith good HIV control

HPV-based screen-and-treat is effective for cervical cancer prevention in HIV-positive women

Clinical benefits of stopping smoking: CVD and CHD risk returns to that of ‘previous smoker’ in HIV-positive people within three years

HIV increases the risk of lung cancer, independent of smoking status

Screening for anal cancer recommended for HIV positive men

Outcomes from screening study for anal cancer in HIV positive compared to HIV negative patients

Higher rates of non-AIDS cancers in HIV positive people

EMEA supports extension of D:A:D study until at least 2012 and the new remit to include non-AIDS cancers and kidney disease

Risk factors for AIDS-defining and non AIDS-defining cancers

Increased anal HPV levels in HV-positive smokers

Limited impact of immunosuppression and HAART on the incidence of cervical squamous intraepithelial lesions in HIV positive women

Elevated risk of lung cancer among people with AIDS

Prevalence and predictors of squamous intraepithelial lesions of the cervix in HIV positive women in Lusaka, Zambia

French study raises importance of early screening for anal cancer in HIV-positive people

Tenofovir did not increase the incidence nephrotoxicity in limited numbers of HIV-positive patients using chemotherapy or HCV-coinfeced patients using ribavirin

Clinical features and predictors of survival in patients with AIDS-related non-Hodgkin’s lymphoma

Surgery and HAART are an effective combination for treating HPV-associated lesions

Increase of non-AIDS defining cancers in HOPS cohort

Stem-cell transplants help beat lymphoma

Rituximab plus CDE for HIV-related Non-Hodgkins Lymphoma (NHL)

Is stress associated with CIN progression in HIV-positive women?

EBV levels in HIV-positive patients are not reduced by HAART

Risk factors for paediatric HIV malignancies

Conference has strong emphasis on women

Rituximab and chemotherapy is highly effective in patients with CD20-positive non-Hodgkin’s lymphoma and HIV

Lung cancer in HIV positive HAART-users

HAART enhances regression of cervical intraepithelial neoplasia in HIV-seropositive women

St John’s Wort interferes with chemotherapy, study shows

HIV-associated malignancies in the HAART era: flickers of hope and understanding

Paclitaxel effective for advanced AIDS-related Kaposi Sarcoma

HAART has little effect on anal cancer precursor lesions or on HPV

AIDS increases risk of non-AIDS-related cancers

Can low-dose shark cartilage shrink KS?

HIV-positive women at high risk for pre-cancerous anal lesions

Incidence of invasive cervical cancer in a cohort of HIV-infected women before and after the introduction of HAART

Cancer risk increased with AIDS

HIV status predicts anal dysphasia and carcinoma risk in HPV-infected individuals

Anal neoplasia grade linked with genetic changes

Spontaneous regression of CIN and delayed-type hypersensitivity to HPV-16 oncoprotein E7

Will cidofovir be useful against cervical lesions?

Human papillomavirus (HPV) may speed HIV progression

High cancer incidence in perinatally HIV-infected children